Camrelizumab plus famitinib in patients with advanced or metastatic kidney cancer
An ongoing phase 2 study of a combination of two [...]
An ongoing phase 2 study of a combination of two [...]
This study looked at the safety and effectiveness of targeted [...]
Recent evidence suggests that the bacteria in the gut (the [...]
The cabozantinib/nivolumab combination has been shown to be effective at [...]
A recent study published in Blood has suggested that cancer [...]
Despite the advances in first-line treatments for metastatic renal cell [...]
The increase in the number of first-line treatments for metastatic [...]
The use of combination therapies for the first-line treatment of [...]
Previous studies have shown that cancer patients who experience immune-related [...]
A study published in The Oncologist recently shows that patients [...]